DE68905516D1 - Hemmungsmittel des zellwachstums der glatten muskeln. - Google Patents
Hemmungsmittel des zellwachstums der glatten muskeln.Info
- Publication number
- DE68905516D1 DE68905516D1 DE8989304369T DE68905516T DE68905516D1 DE 68905516 D1 DE68905516 D1 DE 68905516D1 DE 8989304369 T DE8989304369 T DE 8989304369T DE 68905516 T DE68905516 T DE 68905516T DE 68905516 D1 DE68905516 D1 DE 68905516D1
- Authority
- DE
- Germany
- Prior art keywords
- inhibitors
- cell growth
- smooth muscles
- muscles
- smooth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/189,622 US4945086A (en) | 1988-05-03 | 1988-05-03 | Smooth muscle cell growth inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68905516D1 true DE68905516D1 (de) | 1993-04-29 |
DE68905516T2 DE68905516T2 (de) | 1993-08-12 |
Family
ID=22698106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8989304369T Expired - Fee Related DE68905516T2 (de) | 1988-05-03 | 1989-04-28 | Hemmungsmittel des zellwachstums der glatten muskeln. |
Country Status (4)
Country | Link |
---|---|
US (1) | US4945086A (de) |
EP (1) | EP0341006B1 (de) |
JP (1) | JPH0284402A (de) |
DE (1) | DE68905516T2 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5177020A (en) * | 1985-03-28 | 1993-01-05 | Hoechst Aktiengesellschaft | Method for the immunological determination of heparan sulfate-proteoglycan and process for the preparation and purification of heparan sulfate-proteoglycan suitable for this purpose from tissues containing basal membrane |
US5486599A (en) * | 1989-03-29 | 1996-01-23 | The Board Of Trustees Of The Leland Stanford Junior University | Construction and use of synthetic constructs encoding syndecan |
AU6872691A (en) * | 1989-10-27 | 1991-05-31 | Case Western Reserve University | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
RU2139540C1 (ru) * | 1991-01-15 | 1999-10-10 | Биоти Терапис Лтд. | Способ обнаружения озлокачествления |
WO1992017506A1 (en) * | 1991-03-29 | 1992-10-15 | Glycomed, Inc. | MODULATION OF tPA ACTIVITY BY HEPARIN FRAGMENTS |
GB9111439D0 (en) * | 1991-05-28 | 1991-07-17 | Thrombosis Res Inst | Inhibition of vascular smooth muscle cell proliferation |
US5705178A (en) * | 1991-05-31 | 1998-01-06 | Gliatech, Inc. | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
WO1993005167A1 (en) * | 1991-09-06 | 1993-03-18 | Children's Medical Center Corporation | Cell-type specific heparan sulfate proteoglycans and their uses |
US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
US5665591A (en) * | 1994-12-06 | 1997-09-09 | Trustees Of Boston University | Regulation of smooth muscle cell proliferation |
US6262255B1 (en) | 1995-04-05 | 2001-07-17 | Biomm, Inc. | Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them |
US6146847A (en) * | 1996-11-01 | 2000-11-14 | Genespan Corporation | Stabilized transient gene expression |
FI974321A0 (fi) * | 1997-11-25 | 1997-11-25 | Jenny Ja Antti Wihurin Rahasto | Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa |
DK1588716T3 (da) | 1998-08-06 | 2011-05-23 | Mountain View Pharmaceuticals | Peg-uratoxidase-konjugater og anvendelse deraf |
JP4754137B2 (ja) * | 1999-08-10 | 2011-08-24 | 生化学工業株式会社 | グリコサミノグリカン誘導体およびその使用 |
WO2001037853A2 (en) * | 1999-11-23 | 2001-05-31 | North Shore - Long Island Jewish Health System | Methods and agents for the inhibition of smooth muscle cell proliferation |
US7259152B2 (en) | 2000-06-07 | 2007-08-21 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
BRPI0612942A2 (pt) | 2005-04-11 | 2012-10-09 | Savient Pharmaceuticals Inc | forma variante de oxidase de urato e uso do mesmo |
SI3321359T1 (sl) | 2005-04-11 | 2021-07-30 | Horizon Pharma Rheumatology Llc | Variantne oblike urat oksidaze in uporaba le-teh |
US20080159976A1 (en) * | 2005-04-11 | 2008-07-03 | Jacob Hartman | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
ES2347078T3 (es) | 2005-04-21 | 2010-10-25 | Massachusetts Institute Of Technology | Materiales y metodos para alterar una respuesta inmunologica a inmunogenos exogenos y endogenos, incluyendo celulas, tejidos u organos singeneicos y no singeneicos. |
WO2006125452A1 (en) * | 2005-05-23 | 2006-11-30 | Universite De Geneve | Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
US20090035346A1 (en) | 2005-06-21 | 2009-02-05 | Pervasis Therpeutics, Inc. | Methods and Compositions for Enhancing Vascular Access |
JP5033177B2 (ja) | 2006-04-12 | 2012-09-26 | サビエント ファーマセウティカルズ インク. | 陽イオン界面活性剤によるタンパク質の精製 |
HUP1200205A3 (en) | 2009-06-25 | 2012-09-28 | Savient Pharmaceuticals | Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2281130A2 (fr) * | 1974-08-08 | 1976-03-05 | Thomas Andre | Procede d'extraction et de traitement de glycoproteines, de mucopolysaccharides et de substances qui les accompagnent |
US4446126A (en) * | 1980-09-30 | 1984-05-01 | Cutter Laboratories, Inc. | Antithrombin-heparin complex and method for its production |
DE3381236D1 (de) * | 1982-11-30 | 1990-04-05 | Univ Manchester | Produktion von angiogenen faktoren. |
FR2538404B1 (de) * | 1982-12-28 | 1985-08-23 | Anic Spa | |
US4745098A (en) * | 1984-02-24 | 1988-05-17 | The Regents Of The University Of California | Compositions and method for improving wound healing |
US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
-
1988
- 1988-05-03 US US07/189,622 patent/US4945086A/en not_active Expired - Fee Related
-
1989
- 1989-04-28 EP EP89304369A patent/EP0341006B1/de not_active Expired - Lifetime
- 1989-04-28 DE DE8989304369T patent/DE68905516T2/de not_active Expired - Fee Related
- 1989-05-02 JP JP1112307A patent/JPH0284402A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE68905516T2 (de) | 1993-08-12 |
EP0341006B1 (de) | 1993-03-24 |
US4945086A (en) | 1990-07-31 |
EP0341006A2 (de) | 1989-11-08 |
JPH0284402A (ja) | 1990-03-26 |
EP0341006A3 (en) | 1990-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68905516D1 (de) | Hemmungsmittel des zellwachstums der glatten muskeln. | |
FI865379A (fi) | Belysningsanordning med variabel ljuspunkt foersedd med konstant konvergeringsvinkel. | |
ATE97652T1 (de) | Peptidasehemmungsmittel. | |
FI894539A (fi) | Gaskompressor med torrgastaetningar. | |
FI895769A0 (fi) | Behandling av skinn med selekterade amfifile kopolymerer. | |
FI911172A0 (fi) | Oeverfoeringsanordning med sugvals. | |
FI894849A0 (fi) | Boejningsreglerad vals med tillaeggsmatning. | |
FI880374A (fi) | Skyddshuva eller -film med krympfoermaoga. | |
FI884869A (fi) | I samband med blodprovtagning anvaendbart plaoster. | |
FI896094A0 (fi) | Slangformiga foerpackningshoeljen med foerbaettrad avskalbarhet. | |
FI893871A (fi) | Vals med reglerbar boejning. | |
DE68901509D1 (de) | Hemmstoff der gefaessneubildung. | |
FI906322A0 (fi) | Vaevnadsplasminogenaktivatorer med foerbaettrad aktivitet. | |
FI860226A (fi) | Spiralelementband med skyddade kanter. | |
FI891079A0 (fi) | Foerfarande foer tillverkning av rostat kaffe med foerbaettrade sinnesfoernimbara egenskaper. | |
ATA282688A (de) | Peltonbecher | |
NO891715D0 (no) | Ekspresjon av interferon-8 i metylotrofe gjaersorter. | |
DK69489A (da) | Aspartattranscarbamylase-inhibitorer | |
IT8822885A0 (it) | Attivatore per osteoblasto | |
FI860225A (fi) | Banformningsvira med foerstaerkta kanter. | |
FI893771A0 (fi) | Foersegling med hoelje. | |
FI890783A0 (fi) | Laosanordning foer skaop med draglaodor. | |
FI884296A0 (fi) | Tetrazolinoner substituerade med en fenoxifenyl. | |
FI904235A0 (fi) | Signalprocessystem foer vidskaermstelevision med jaemn bildresolution foer mitt- och sidoband. | |
FI885167A0 (fi) | Foerfarande foer saenkning av maengden kvaeveoxider i avgaser med anvaendning av heterocykliskt kolvaete. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |